BPC-157, a gastric pentadecapeptide derived from proteolytic enzyme preparations, and TB-500, a synthetic analogue of thymosin beta-4, represent emerging agents with broad biological activity relevant to tissue repair and cytoprotection
There is no receptor to desensitise on a fast clock, and no acute spike to time around a meal
Drucker, D
Both peptides lack tumor-promoting activity in published studies, and neither affects cortisol, prolactin, or other hormonal axes
Our professional conclusion is this: No, not directly
Adverse drug reactions observed in the mecobalamin 50 mg group were constipation, injection site pain, fever, electrocardiogram QT prolongation, and rash, occurring in 1.5% (1/65 cases) each